Europe Biosimilar Monoclonal Antibodies Market Report 2016
- QYR711798
- 127 Pages
- October 2016
- Medical Devices
Sales, means the sales volume of Biosimilar Monoclonal Antibodies
Revenue, means the sales value of Biosimilar Monoclonal Antibodies
This report studies sales (consumption) of Biosimilar Monoclonal Antibodies in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Celltrion
Boehringer Ingelheim
Dr Reddy’s
Sandoz
Zydus
Samsung
Amgen
Hospira
Shanghai CP Guojian Pharmaceutical
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Biosimilar Monoclonal Antibodies in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on sales, market share and growth rate of Biosimilar Monoclonal Antibodies in each application, can be divided into
Application 1
Application 2
Application 3
Europe Biosimilar Monoclonal Antibodies Market Report 2016
1 Biosimilar Monoclonal Antibodies Overview
1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies
1.2 Classification of Biosimilar Monoclonal Antibodies
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Biosimilar Monoclonal Antibodies
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Biosimilar Monoclonal Antibodies Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Biosimilar Monoclonal Antibodies (2011-2021)
1.5.1 Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2021)
1.5.2 Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)
2 Europe Biosimilar Monoclonal Antibodies by Manufacturers, Type and Application
2.1 Europe Biosimilar Monoclonal Antibodies Market Competition by Manufacturers
2.1.1 Europe Biosimilar Monoclonal Antibodies Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Biosimilar Monoclonal Antibodies Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Biosimilar Monoclonal Antibodies (Volume and Value) by Type
2.2.1 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2011-2016)
2.2.2 Europe Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2011-2016)
2.3 Europe Biosimilar Monoclonal Antibodies (Volume and Value) by Countries
2.3.1 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Biosimilar Monoclonal Antibodies Revenue and Market Share by Countries (2011-2016)
2.4 Europe Biosimilar Monoclonal Antibodies (Volume) by Application
3 Germany Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
3.1 Germany Biosimilar Monoclonal Antibodies Sales and Value (2011-2016)
3.1.1 Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
3.1.2 Germany Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
3.1.3 Germany Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
3.2 Germany Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
3.3 Germany Biosimilar Monoclonal Antibodies Sales and Market Share by Type
3.4 Germany Biosimilar Monoclonal Antibodies Sales and Market Share by Application
4 France Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
4.1 France Biosimilar Monoclonal Antibodies Sales and Value (2011-2016)
4.1.1 France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
4.1.2 France Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
4.1.4 France Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
4.2 France Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
4.3 France Biosimilar Monoclonal Antibodies Sales and Market Share by Type
4.4 France Biosimilar Monoclonal Antibodies Sales and Market Share by Application
5 UK Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
5.1 UK Biosimilar Monoclonal Antibodies Sales and Value (2011-2016)
5.1.1 UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
5.1.2 UK Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
5.1.5 UK Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
5.2 UK Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
5.3 UK Biosimilar Monoclonal Antibodies Sales and Market Share by Type
5.4 UK Biosimilar Monoclonal Antibodies Sales and Market Share by Application
6 Russia Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
6.1 Russia Biosimilar Monoclonal Antibodies Sales and Value (2011-2016)
6.1.1 Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
6.1.2 Russia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
6.1.6 Russia Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
6.2 Russia Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
6.3 Russia Biosimilar Monoclonal Antibodies Sales and Market Share by Type
6.4 Russia Biosimilar Monoclonal Antibodies Sales and Market Share by Application
7 Italy Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
7.1 Italy Biosimilar Monoclonal Antibodies Sales and Value (2011-2016)
7.1.1 Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
7.1.2 Italy Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
7.1.7 Italy Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
7.2 Italy Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
7.3 Italy Biosimilar Monoclonal Antibodies Sales and Market Share by Type
7.4 Italy Biosimilar Monoclonal Antibodies Sales and Market Share by Application
8 Spain Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
8.1 Spain Biosimilar Monoclonal Antibodies Sales and Value (2011-2016)
8.1.1 Spain Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
8.1.2 Spain Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
8.1.8 Spain Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
8.2 Spain Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
8.3 Spain Biosimilar Monoclonal Antibodies Sales and Market Share by Type
8.4 Spain Biosimilar Monoclonal Antibodies Sales and Market Share by Application
9 Benelux Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price)
9.1 Benelux Biosimilar Monoclonal Antibodies Sales and Value (2011-2016)
9.1.1 Benelux Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
9.1.2 Benelux Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
9.2 Benelux Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturers
9.3 Benelux Biosimilar Monoclonal Antibodies Sales and Market Share by Type
9.4 Benelux Biosimilar Monoclonal Antibodies Sales and Market Share by Application
10 Europe Biosimilar Monoclonal Antibodies Manufacturers Analysis
10.1 Celltrion
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Boehringer Ingelheim
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Dr Reddy’s
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Sandoz
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Sandoz Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Zydus
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Zydus Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Samsung
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Samsung Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Amgen
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Amgen Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Hospira
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Hospira Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Shanghai CP Guojian Pharmaceutical
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
11 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis
11.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Biosimilar Monoclonal Antibodies Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Biosimilar Monoclonal Antibodies Market Forecast (2016-2021)
14.1 Germany Biosimilar Monoclonal Antibodies Sales Forecast (2016-2021)
14.2 France Biosimilar Monoclonal Antibodies Sales Forecast (2016-2021)
14.3 UK Biosimilar Monoclonal Antibodies Sales Forecast (2016-2021)
14.4 Russia Biosimilar Monoclonal Antibodies Sales Forecast (2016-2021)
14.5 Italy Biosimilar Monoclonal Antibodies Sales Forecast (2016-2021)
14.6 Spain Biosimilar Monoclonal Antibodies Sales Forecast (2016-2021)
14.7 Benelux Biosimilar Monoclonal Antibodies Sales Forecast (2016-2021)
14.8 Europe Biosimilar Monoclonal Antibodies Sales Forecast by Type (2016-2021)
14.9 Europe Biosimilar Monoclonal Antibodies Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Biosimilar Monoclonal Antibodies
Table Classification of Biosimilar Monoclonal Antibodies
Figure Europe Sales Market Share of Biosimilar Monoclonal Antibodies by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Biosimilar Monoclonal Antibodies
Figure Europe Sales Market Share of Biosimilar Monoclonal Antibodies by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)
Figure France Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)
Figure UK Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)
Figure Russia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)
Figure Italy Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)
Figure Spain Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)
Figure Benelux Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)
Figure Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2021)
Figure Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)
Table Europe Biosimilar Monoclonal Antibodies Sales of Key Manufacturers (2015 and 2016)
Table Europe Biosimilar Monoclonal Antibodies Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilar Monoclonal Antibodies Sales Share by Manufacturers
Figure 2016 Biosimilar Monoclonal Antibodies Sales Share by Manufacturers
Table Europe Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2015 and 2016)
Table Europe Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers
Table 2016 Europe Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers
Table Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2011-2016)
Table Europe Biosimilar Monoclonal Antibodies Sales Share by Type (2011-2016)
Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Type (2011-2016)
Figure Europe Biosimilar Monoclonal Antibodies Sales Growth Rate by Type (2011-2016)
Table Europe Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2011-2016)
Table Europe Biosimilar Monoclonal Antibodies Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Type (2011-2016)
Figure Europe Biosimilar Monoclonal Antibodies Revenue Growth Rate by Type (2011-2016)
Table Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Countries (2011-2016)
Table Europe Biosimilar Monoclonal Antibodies Sales Share by Countries (2011-2016)
Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Countries (2011-2016)
Table Europe Biosimilar Monoclonal Antibodies Revenue and Market Share by Countries (2011-2016)
Table Europe Biosimilar Monoclonal Antibodies Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Countries (2011-2016)
Table Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Application (2011-2016)
Table Europe Biosimilar Monoclonal Antibodies Sales Share by Application (2011-2016)
Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Application (2011-2016)
Figure Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
Figure Germany Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
Figure Germany Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
Table Germany Biosimilar Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table Germany Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table Germany Biosimilar Monoclonal Antibodies Sales by Type (2015 and 2016)
Table Germany Biosimilar Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table Germany Biosimilar Monoclonal Antibodies Sales by Application (2015 and 2016)
Table Germany Biosimilar Monoclonal Antibodies Market Share by Application (2015 and 2016)
Figure France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
Figure France Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
Figure France Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
Table France Biosimilar Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table France Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table France Biosimilar Monoclonal Antibodies Sales by Type (2015 and 2016)
Table France Biosimilar Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table France Biosimilar Monoclonal Antibodies Sales by Application (2015 and 2016)
Table France Biosimilar Monoclonal Antibodies Market Share by Application (2015 and 2016)
Figure UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
Figure UK Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
Figure UK Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
Table UK Biosimilar Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table UK Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table UK Biosimilar Monoclonal Antibodies Sales by Type (2015 and 2016)
Table UK Biosimilar Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table UK Biosimilar Monoclonal Antibodies Sales by Application (2015 and 2016)
Table UK Biosimilar Monoclonal Antibodies Market Share by Application (2015 and 2016)
Figure Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
Figure Russia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
Figure Russia Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
Table Russia Biosimilar Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table Russia Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table Russia Biosimilar Monoclonal Antibodies Sales by Type (2015 and 2016)
Table Russia Biosimilar Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table Russia Biosimilar Monoclonal Antibodies Sales by Application (2015 and 2016)
Table Russia Biosimilar Monoclonal Antibodies Market Share by Application (2015 and 2016)
Figure Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
Figure Italy Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
Figure Italy Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
Table Italy Biosimilar Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table Italy Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table Italy Biosimilar Monoclonal Antibodies Sales by Type (2015 and 2016)
Table Italy Biosimilar Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table Italy Biosimilar Monoclonal Antibodies Sales by Application (2015 and 2016)
Table Italy Biosimilar Monoclonal Antibodies Market Share by Application (2015 and 2016)
Figure Spain Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
Figure Spain Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
Figure Spain Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
Table Spain Biosimilar Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table Spain Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table Spain Biosimilar Monoclonal Antibodies Sales by Type (2015 and 2016)
Table Spain Biosimilar Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table Spain Biosimilar Monoclonal Antibodies Sales by Application (2015 and 2016)
Table Spain Biosimilar Monoclonal Antibodies Market Share by Application (2015 and 2016)
Figure Benelux Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2016)
Figure Benelux Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2016)
Figure Benelux Biosimilar Monoclonal Antibodies Sales Price Trend (2011-2016)
Table Benelux Biosimilar Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)
Table Benelux Biosimilar Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)
Table Benelux Biosimilar Monoclonal Antibodies Sales by Type (2015 and 2016)
Table Benelux Biosimilar Monoclonal Antibodies Market Share by Type (2015 and 2016)
Table Benelux Biosimilar Monoclonal Antibodies Sales by Application (2015 and 2016)
Table Benelux Biosimilar Monoclonal Antibodies Market Share by Application (2015 and 2016)
Table Biosimilar Monoclonal Antibodies Basic Information List
Table Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celltrion Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Dr Reddy’s Basic Information List
Table Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr Reddy’s Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Zydus Basic Information List
Table Zydus Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zydus Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Samsung Basic Information List
Table Samsung Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Samsung Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Shanghai CP Guojian Pharmaceutical Basic Information List
Table Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
Figure Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
Figure Biosimilar Monoclonal Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
Table Major Buyers of Biosimilar Monoclonal Antibodies
Table Distributors/Traders List
Figure Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)
Figure Germany Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)
Figure France Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)
Figure France Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)
Figure UK Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)
Figure UK Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)
Figure Russia Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)
Figure Italy Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)
Figure Spain Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)
Table Europe Biosimilar Monoclonal Antibodies Sales Forecast by Type (2016-2021)
Table Europe Biosimilar Monoclonal Antibodies Sales Forecast by Application (2016-2021)
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
